The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease (Q90822228)
Jump to navigation
Jump to search
scientific article published on 31 March 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease |
scientific article published on 31 March 2020 |
Statements
The belated US FDA approval of the adenosine A2A receptor antagonist istradefylline for treatment of Parkinson's disease (English)